Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

BACKGROUND: Procalcitonin (PCT) testing can help in safely reducing antibiotic treatment duration in intensive care patients with sepsis. However, the cost-effectiveness of such PCT guidance is not yet known. METHODS: A trial-based analysis was performed to estimate the cost-effectiveness of PCT guidance compared with standard of care (without PCT guidance). Patient-level data were used from the SAPS trial in which 1546 patients were randomised. This trial was performed in the Netherlands, which is a country with, on average, low antibiotic use and a short duration of hospital stay. As quality... Mehr ...

Verfasser: Kip, Michelle M A
van Oers, J.A.
Shajiei, A
Beishuizen, Albertus
Girbes, A.R.J.
de Jong, E
de Lange, DW
Nijsten, Maarten W N
IJzerman, M.J.
Koffijberg, H
Kusters, R.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Schlagwörter: Adult / Anti-Bacterial Agents/administration & dosage / Biomarkers/analysis / Cost-Benefit Analysis/standards / Critical Illness/economics / Female / Hospital Mortality / Humans / Intensive Care Units/economics / Length of Stay/economics / Male / Netherlands / Procalcitonin/analysis / Prospective Studies / Sepsis/blood / Time Factors / Journal Article / Multicenter Study / Randomized Controlled Trial
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27611037
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/372977